Diseases

Hyperimmunoglobinemia D with recurrent fever

Hyperimmunoglobulinemia D with recurrent fever (commonly abbreviated as HIDS) is a periodic fever syndrome originally described in 1984 by the internist Prof. Jos van der Meer, then at Leiden University Medical Centre. No more than 300 cases have been described worldwide.

Hyperinsulinemic hypoglycemia- familial- 1

A disorder where too much insulin causes low blood sugar in infants. Prompt treatment is needed to avoid the brain being damaged by repeated periods of low blood sugar. The various types of familial hyperinsulinemic hypoglycemia are distinguished by their genetic origin. HHF1 is due to a mutation in the gene for SUR1 (surfonlyurea receptor 1) on chromosome 11p15.1.

Hyperkalemic periodic paralysis

Hyperkalemic periodic paralysis (HYPP), also known as Impressive Syndrome, is an inherited autosomal dominant disorder which affects sodium channels in muscle cells and the ability to regulate potassium levels in the blood. It is most commonly associated with horses, but also occurs in humans, where it is also called Gamstorp episodic adynamy.

Hyperkeratosis lenticularis perstans

Flegel originally described hyperkeratosis lenticularis perstans (HLP) in 1958 as red-brown papules with horny scales of irregular outline measuring 1-5 mm in diameter and up to 1 mm in depth. Lesions are located primarily on the dorsal feet and lower legs, with a decreasing likelihood of manifestation proximally. Most cases have been reported in Europe.

Hyperlipoproteinemia type 1

Hyperlipoproteinemia type 1 is a genetic disorder characterized by abnormal lipid (chylomicrons and high triglyceride lipids) breakdown which results in its accumulation in the blood. The disorder is caused by the reduced or absent activity of the enzyme lipoprotein lipase. The severity of the condition is determined by the degree of the deficiency and treatment. The disorder tends to run in families (familial).

Hyperlipoproteinemia type 3

A rare genetic disorder characterized by the body's impaired ability to break down certain lipids (triglycerides) which results in their buildup in the blood.

Hyperlipoproteinemia type 5

An inherited disorder where the body's ability to break down lipids (triglycerides and cholesterol) is impaired resulting in increased blood lipid levels of chylomicrons and VLDL's

Hyperlysinemia

Hyperlysinemia is an autosomal recessive metabolic disorder characterized by an abnormal increase of lysine in the blood, but appears to be benign. It can be associated with saccharopine dehydrogenase.

Hyperornithinemia

Elevated levels of ornithine in the serum; sometimes associated with hyperammonemia and homocitrullinuria.

Hyperornithinemia-hyperammonemia-homocitrullinuria

A very rare inherited metabolic disorder where ammonia builds up in the body due to a defect in the transport of ornithine which prevents ammonia being converted to urea and being excreted through the urine. The severity of the condition is variable.

Hyperostosis cortical infantile

A rare inflammatory disorder that affects bones and soft tissue in infants. The condition may affect virtually any bone and causes excessive enlargement of part of the bone (cortex). Infant feeding problems may occur if the jaw bone is affected which can affect weight gain. The inflammatory course of the disease eventually stops and over time the bones remodel to a normal appearance

Hyperostosis corticalis generalisata

A rare genetic disorder characterized by increased thickening of the bones in the skull, jaw, collar bone, ribs and the main shaft of long bones. The thickening of the bones may compress some nerves resulting in vision and hearing impairment.

Hyperoxaluria

Hyperoxaluria (called Bird's disease, after Golding Bird, who first described the condition), is an excessive urinary excretion of oxalate. Individuals with hyperoxaluria often have calcium oxalate kidney stones.

Hyperparathyroidism- familial- primary

Primary hyperparathyroidism causes hypercalcemia (elevated blood calcium levels) through the excessive secretion of parathyroid hormone (PTH), usually by an adenoma (benign tumors) of the parathyroid glands. Its incidence is approximately 42 per 100,000 people. It is almost exactly three times as common in women as men.

Hyperphenilalaninemia due to pterin-4-alpha-carbin

A rare metabolic disorder where the deficiency of an enzyme (pterin-4-alpha-carbinolamine dehydratase) can caused high blood phenylalanine levels. The condition is generally harmless and the disorder is usually only discovered accidentally in routine blood tests.

Hyperphenylalalinemia due to dihydropteridine reductase deficiency

A genetic condition where phenylalanine (component of protein) is unable to be broken down due to an enzyme (phenylalanine hydroxylase) deficiency which leads to a harmful build up of the compound. The condition is characterized by neurological symptoms as well as the presence of increased levels of phenylalanine in the blood.

Hyperphenylalaninemia due to dehydratase deficiency

A rare metabolic disorder where the deficiency of an enzyme (pterin-4-alpha-carbinolamine dehydratase) can caused high blood phenylalanine levels. The condition is generally harmless and the disorder is usually only discovered accidentally in routine blood tests.

Hyperphenylalaninemia with primapterinuria

A rare disorder characterized by high blood phenylalanine levels and excretion of primapterine in the urine due to an enzyme deficiency (pterin-4-alpha-carbinolamine dehydratase). The condition usually produces no clinical symptoms.